Alignment with National Health Security Goals: GeoVax’s focus on U.S.-based vaccine production supports HHS’s priority of reducing dependency on foreign pharmaceutical supply chains, ensuring ...

Strengthening U.S. Biodefense. ATLANTA, GA - March 3, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a leader in developing vaccines and immunotherapi ...

In this case, although a vaccine made by inactivated viral surface antigen (HBsAg) was shown to be effective in the seventies, vaccine manufacture was limited since the antigen could only be ...

Another hemorrhagic threat is Lassa Fever, a virus in West Africa infecting between 100,000 and 300,000 people annually, ...